Martin Köbel

Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

Francesmary Modugno, Christine Chow, Ellen L Goode, 2013, Cancer Epidemiology, Biomarkers & Prevention.

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Anna Adamiak, Russell Vang, C Blake Gilks, 2009, BMC Cancer.

Ezrin Promotes Ovarian Carcinoma Cell Invasion and Its Retained Expression Predicts Poor Prognosis in Ovarian Carcinoma

Steffen Hauptmann, Jürgen Dittmer, Christoph Thomssen, 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

Nhu Le, C Blake Gilks, N. Le, 2008, Human pathology.

Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian Study

Samuel Leung, C Blake Gilks, David G Huntsman, 2010, The American journal of surgical pathology.

Reproducibility of histological cell type in high-grade endometrial carcinoma

M. Köbel, S. Kalloger, P. Clement, 2013, Modern Pathology.

Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

Dongxia Gao, Rebecca O Barnes, M. Köbel, 2009, PloS one.

Implementation of a Canadian External Quality Assurance Program for Breast Cancer Biomarkers: An Initiative of Canadian Quality Control in Immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry

Richard Berendt, Louis Gaboury, Anthony Magliocco, 2009, Applied immunohistochemistry & molecular morphology : AIMM.

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma

Sohrab P Shah, Jiarui Ding, Janine Senz, 2012, Modern Pathology.

Activation of mitogen-activated protein kinase is required for migration and invasion of placental site trophoblastic tumor.

Steffen Hauptmann, Tian-Li Wang, Ie-Ming Shih, 2005, The American journal of pathology.